macrobid and semaglutide in patients with overweight or obesity chronic kidney disease without diabetes: a randomized double-blind placebo-controlled clinical trial Is Ozempic Safe for Your

Zhang H, Zhang Y, Yin T, Wang J, Zhang X (2019) Heterologous expression and characterization of a novel ochratoxin A degrading enzyme, N-acyl-L-amino acid amidohydrolase, from Alcaligenes faecalis

Preclinical research demonstrates its ability to accelerate mucosal healing in the stomach and esophagus, reduce gastric acid hypersecretion, and modulate inflammatory cytokine pathways implicated in reflux esophagitis

Activation of the reverse transsulfuration pathway through NRF2/CBS confers erastin-induced ferroptosis resistance

A report published last week by the Business Group on Health estimates large employers are preparing for a 7.8% spike in healthcare costs next year, largely due to increased spending on pharmaceuticals like GLP-1s

In the AMPLITUDE-O trial, 15% of the subjects were on SGLT-2i and the authors state that the overlap between the RR 95% confidence interval for CV events suggests no interaction

This is not sick care